首页 | 本学科首页   官方微博 | 高级检索  
检索        

TLR4/MAPKs信号通路在ox-LDL诱导的血管平滑肌细胞分泌MCP-1中的作用
引用本文:徐斌,张延斌,许旭光,王大杰,徐通达,李东野.TLR4/MAPKs信号通路在ox-LDL诱导的血管平滑肌细胞分泌MCP-1中的作用[J].中国病理生理杂志,2010,26(5):848-852.
作者姓名:徐斌  张延斌  许旭光  王大杰  徐通达  李东野
作者单位:徐州医学院附属医院心内科,江苏 徐州 221002
摘    要:目的:探讨Toll样受体4/丝裂原活化蛋白激酶(TLR4/MAPKs)信号通路在氧化性低密度脂蛋白(ox-LDL)诱导的血管平滑肌细胞分泌单核细胞趋化因子-1(MCP-1)中的作用。方法:在ox-LDL刺激下采用逆转录聚合酶链技术(RT-PCR)和酶联免疫吸附试验(ELISA)检测血管平滑肌细胞MCP-1的表达,用Western blotting检测细胞外信号调节激酶(ERK1/2)、p38促分裂原活化蛋白激酶(p38MAPK)磷酸化水平的变化。同时,分别应用TLR4中和抗体(TLR4单克隆抗体、TLR4阻断剂)、PD98059(ERK1/2特异性抑制剂)、SB23015(p38MAPK特异性抑制剂)、SP600125(JNK特异性抑制剂),观察其对ox-LDL诱导的MCP-1的表达和ERK1/2、p38MAPK磷酸化水平的影响。结果:ox-LDL刺激血管平滑肌细胞上调MCP-1mRNA和其蛋白的表达(P0.05);用TLR4中和抗体、PD98059、SB23015预孵育后MCP-1mRNA和其蛋白的表达较单独ox-LDL刺激情况下降低(P0.05),而用SP600125预孵育后降低不明显(P0.05);TLR4调节了ERK1/2和p38MAPKs的磷酸化水平。结论:ox-LDL是TLR4的内源性配体;ox-LDL通过或部分通过TLR4/ERK1/2和TLR4/p38MAPK信号通路介导血管平滑肌细胞MCP-1的表达。

关 键 词:氧化性低密度脂蛋白  Toll样受体-4  单核细胞趋化蛋白-1  平滑肌细胞  动脉粥样硬化  
收稿时间:2009-10-22
修稿时间:2010-3-4

Role of Toll-like receptor 4/MAPKs pathway on monocyte chemoattractant protein-1 secretion induced by oxidized low density lipoprotein in vascular smooth muscle cells
XU Bin,ZHANG Yan-bin,XU Xu-guang,WANG Da-jie,XU Tong-da,LI Dong-ye.Role of Toll-like receptor 4/MAPKs pathway on monocyte chemoattractant protein-1 secretion induced by oxidized low density lipoprotein in vascular smooth muscle cells[J].Chinese Journal of Pathophysiology,2010,26(5):848-852.
Authors:XU Bin  ZHANG Yan-bin  XU Xu-guang  WANG Da-jie  XU Tong-da  LI Dong-ye
Institution:Department of Cardiology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China. E-mail: zhangyanbin99@sina. com
Abstract:AIM: To investigate the role of Toll-like receptor 4/MAPKs pathway on the secretion of monocyte chemoattractant protein-1 (MCP-1) induced by oxidized low density lipoprotein (ox-LDL) in the vascular smooth muscle cells (VSMCs). METHODS: mRNA and protein expressions of MCP-1 in VSMCs stimulated with oxidized low density lipoprotein were determined by RT-PCR and ELISA, respectively. The phosphorylated forms of ERK1/2 and p38MAPK were determined by Western blotting. TLR4 neutralizing antibodies (a specific TLR4 inhibitor), PD98059 (ERK1/2 specific inhibitor), SB23015 (p38MAPK specific inhibitor) and SP600125 (JNK specific inhibitor) were used to investigate the underlying mechanisms. RESULTS: The mRNA and protein expressions of MCP-1 in VSMCs were up-regulated by ox-LDL (P<0.05), while those were inhibited by TLR4 neutralizing antibodies, PD98059 or SB23015 (P<0.05), but not by SP600125 (P>0.05). TLR4 had regulatory effect on the phosphorylation of ERK1/2 and p38MAPK. CONCLUSION: ox-LDL is an endogenous ligand of TLR4. The secretion of MCP-1 induced by ox-LDL in VSMCs is at least in part via TLR4/ERK1/2 and TLR4/p38MAPKs pathways.
Keywords:Oxidized low density lipoprotein  Toll-like receptor 4  Monocyte chemoattractant protein-1  Smooth muscle cells  Atherosclerosis
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号